"Icon Cancer Centre Farrer Park offers a full range of cancer treatments and blood disorder treatments. The centre is easily accessible via Farrer Park MRT station and is co-located to hospital and hotel. Treatment options include radiation therapy, chemotherapy, immunotherapy, targeted therapies, treatment for blood disorders, hormone therapy and cancer screening and diagnosis. The centre offers access to scalp cooling systems, pathology, pharmacy, allied health and PET-CT imaging services are available on the hospital campus. The centre has a team of medical oncologists, radiation oncologists, haematologists and oncology nurses who are focused on ensuring optimum patient safety and comfort throughout their treatment journey."

During the past decade, Icon Cancer Centre Farrer Park conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Icon Cancer Centre Farrer Park" #1 collaborator was "BeiGene, Ltd." with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Everest Medicines" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Icon Cancer Centre Farrer Park" are "Esophageal Adenocarcinoma" (1 trials), "Gastric Adenocarcinoma" (1 trials), "Gastric Cancer" (1 trials), "Gastric Neoplasms" (1 trials) and "Gastroesophageal Adenocarcinoma" (1 trials). Many other conditions were trialed in "Icon Cancer Centre Farrer Park" in a lesser frequency.

Most popular intervention types in "Icon Cancer Centre Farrer Park" are "Drug" (3 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (2 trials), "Trastuzumab" (2 trials), "5-Fluorouracil" (1 trials), "Capecitabine" (1 trials) and "Cisplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Icon Cancer Centre Farrer Park" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Icon Cancer Centre Farrer Park". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Icon Cancer Centre Farrer Park, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Icon Cancer Centre Farrer Park, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".